These disorders are associated with a range of symptoms, including anorexia, weight loss, impaired neural function, mental problems, muscle weakness and heart enlargement
PMID 33404559
Research and development costs play a role in pricing, but ultimately, semaglutide is not a very pricey peptide, and pharmaceutical companies are able to charge high fees as there are very few corporations making this kind of drug
Let's examine that some more
Regul Pept 167(23):177184 Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour J-F, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Jrvinen H, Fan J-G, Grnbk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng M-H, Fouad Y, Chan W-K, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J (2020) A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement